Kyntra Bio, Inc. (KYNB)
NASDAQ: KYNB · Real-Time Price · USD
8.01
-0.76 (-8.67%)
Jan 29, 2026, 4:00 PM EST - Market closed
Kyntra Bio Employees
Kyntra Bio had 225 employees as of December 31, 2024. The number of employees decreased by 261 or -53.70% compared to the previous year.
Employees
225
Change (1Y)
-261
Growth (1Y)
-53.70%
Revenue / Employee
$36,880
Profits / Employee
$958,462
Market Cap
32.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 225 | -261 | -53.70% |
| Dec 31, 2023 | 486 | -106 | -17.91% |
| Dec 31, 2022 | 592 | 26 | 4.59% |
| Dec 31, 2021 | 566 | -33 | -5.51% |
| Dec 31, 2020 | 599 | 68 | 12.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Passage Bio | 60 |
| Cue Biopharma | 41 |
| Lantern Pharma | 24 |
| AN2 Therapeutics | 22 |
| TuHURA Biosciences | 19 |
| Outlook Therapeutics | 17 |
| Skye Bioscience | 16 |
KYNB News
- 22 days ago - FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum - GlobeNewsWire
- 2 months ago - FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - FibroGen to Report Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - FibroGen Initiates Phase 2 Monotherapy Trial of FG-3246, a First-in-Class CD46 Targeting ADC, in Metastatic Castration-Resistant Prostate Cancer - GlobeNewsWire
- 5 months ago - FibroGen to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - FibroGen Announces Approval of Sale of FibroGen China to AstraZeneca by the China State Administration for Market Regulation - GlobeNewsWire
- 6 months ago - FibroGen, Inc. (FGEN) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - FibroGen Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire